A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

December 23, 2017

Study Completion Date

December 23, 2017

Conditions

Healthy

Interventions

DRUG

Lasmiditan

Administered orally

DRUG

Sumatriptan

Administered orally

DRUG

Placebo for Lasmiditan

Administered orally

DRUG

Placebo for Sumatriptan

Administered orally

Trial Locations (1)

Covance Daytona Beach, Daytona Beach

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03310411 - A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants | Biotech Hunter | Biotech Hunter